FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer
In Brief: Louise Strong Named President, AACR; Donald Coffey Is President-Elect
Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says
House Committee Asks Varmus About Impact of Clinical Center construction On NIH Programs
Centers May Become More specialized, Klausner Tells AACI
NIH, NCI Being Discussions With HCFA On Reimbursement
Trending Stories
- She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research
- Rick and Mary Pazdur on facing “the other side of the stethoscope”
A few months before Mary died of ovarian cancer, the couple shared how this experience shaped their perspectives on oncology - Imaging’s ride to the bottom in clinical trials—and why it matters now
- NIH says it’s moving away from animal-based models
- The Directors: Mark Evers and Steven Libutti on riding out the tempest—and maintaining research momentum
As oncology braces for funding, Medicaid cuts, these two directors tell young investigators not to panic - ODAC nixes GSK’s Blenrep myeloma regimens, citing ocular toxicity, dosing, applicability to U.S. population